Congratulations to Elizabeth Bulaeva from the Eaves Lab for successfully defending her thesis
Elizabeth Bulaeva (Eaves Lab) successfully defended her PhD thesis entitled “Analysis of a de novo c-MYC-induced model of human Acute Myeloid Leukemia”.
News
A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers
Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia.
Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers.
Afsaneh Mojtabanezhad Shariatpanahi awarded four-year doctoral fellowship (4YF)
Congratulations to Afsaneh who has been awarded a 4YF from the IOP program for her project entitled “Elucidating the molecular mechanism of high-risk multiple myeloma”.
Liam MacPhee (Kuchenbauer Lab) awarded BC Graduate Scholarship
Congratulations to Liam who has been awarded a B.C. Graduate Scholarship for his project entitled “Investigating the anti-leukemic effects of tumor-suppressor microRNAs in acute myeloid leukemia”.
Sibyl Drissler (Hoodless Lab) awarded CIHR Canada Graduate Scholarship Master's (CGSM) Award
Congratulations to Sibyl Drissler (Hoodless Lab) who has been awarded a CIHR Canada Graduate Scholarship Master's (CGSM) Award.
Sherrie X Wang (Brinkman Lab) defends her MSc thesis entitled “Flow cytometry data analysis pipeline – data quality control tool development and biomarker discovery”
Congratulations to Sherrie X Wang from the Brinkman Lab, who successfully defended her MSc thesis entitled “Flow cytometry data analysis pipeline – data quality control tool development and biomarker discovery” on April 8, 2020.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.